Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the...

UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that it is releasing a course on Disease Modeling...

AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification New York, May 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced today that it is releasing a course on Disease...

Governor Northam, University of Virginia Biocomplexity Institute, RAND Corporation Present Infectious Disease Modeling on Impact of COVID-19 Mitigations in Virginia Richmond, Va., April 14, 2020 (GLOBE NEWSWIRE) -- Governor Ralph Northam, in partnership with researchers from the University of Virginia’s Biocomplexity Institute and the nonprofit RAND...

SNS FiRe Conference Names ORIG3N Inc. a 2016 FiReStarter Company SEATTLE, WA--(Marketwired - September 15, 2016) - Strategic News Service (SNS) has selected ORIG3N Inc. as a 2016 FiReStarter company to be featured at the 14th annual Future in Review (FiRe)...